Rigenil Hair Loss Treatment Gel10 vials 8 ml

Anti-hair loss and regrowth treatment based on phytotherapeutic substances of natural origin, suitable for counteracting temporary loss and promoting hair growth. Anti-hair loss ampoules: the first clinically certified complete hair project.

How to use
1. Twist the top of the bottle cannula until it is removed.
2. Turning the cannula of the bottle towards the skin, dose the liquid by pressing the swollen part under the cannula.
Apply by distributing the contents of a single-dose vial directly on the scalp through a circular massage with the fingertips until completely absorbed. Do not rinse. The product can be applied to dry or wet and buffered scalp.
Use 2 ampoules a week for 90 days, 1 every 3 days. We recommend 2 treatments per year (Spring and Autumn) of 90 days each.

Components
Tamarind extract, grape proanthocyanidins, thuja occidentalis, mallow, caffeine, taraxacum officinalis .

Format
Box containing 10 ampoules of 8 ml (corresponding to one month of treatment).

Cod. 996FL

The images of the products are purely indicative and may therefore not be perfectly representative of the packaging, the characteristics of the product, differing in color, size or content. Any decorations, gift boxes and objects included in the images for the purpose of presenting the product will not be shipped in the orders. The product names, ingredients and percentages indicated in the descriptions are purely indicative, they may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to these updates, the photos and technical information of the products posted on xfarma.it may differ from those shown on the label or otherwise disseminated by the manufacturers. The only identification element is the MINSAN ministerial code. The xfarma.it pharmacy does not guarantee the truthfulness and topicality of the information published and declines all responsibility for any errors, omissions or missing updates thereof. xfarma.it assumes no responsibility for damages of any nature that may derive from access to the information published.